CN106496091A - A kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof - Google Patents

A kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof Download PDF

Info

Publication number
CN106496091A
CN106496091A CN201610876090.XA CN201610876090A CN106496091A CN 106496091 A CN106496091 A CN 106496091A CN 201610876090 A CN201610876090 A CN 201610876090A CN 106496091 A CN106496091 A CN 106496091A
Authority
CN
China
Prior art keywords
dicarbapentaborane
substituted azole
azole class
preparation
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610876090.XA
Other languages
Chinese (zh)
Other versions
CN106496091B (en
Inventor
闫建伟
李昆
倪天军
闫福林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinxiang Medical University
Original Assignee
Xinxiang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinxiang Medical University filed Critical Xinxiang Medical University
Priority to CN201610876090.XA priority Critical patent/CN106496091B/en
Publication of CN106496091A publication Critical patent/CN106496091A/en
Application granted granted Critical
Publication of CN106496091B publication Critical patent/CN106496091B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof, belong to the synthesis technical field of azole derivatives.Technical scheme main points are:A kind of 2 dicarbapentaborane substituted azole class compounds, with following general structure:.The invention also discloses the preparation method of 2 dicarbapentaborane substituted azole class compounds.The present invention realizes the double carbonylation of pyrroles 2 by a step cascade reaction, has synthesized a series of multiple functionalized 2 dicarbapentaborane substituted azole class compounds, is its further derivatization research, synthesizes the drug molecule containing pyrrole structure and lay a good foundation.

Description

A kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof
Technical field
The invention belongs to the synthesis technical field of azole derivatives, and in particular to a kind of 2 dicarbapentaborane substituted azole classes Compound and preparation method thereof.
Background technology
Pyrrole heterocyclic is widely present in bioactive natural product and drug molecular structure, with blood fat reducing, antibacterial, antitumor With multiple biological activities such as antiviral.Wherein, the azoles of 2 dicarbapentaborane replacements are important active organic points of a class Son, up to now, its preparation method is mainly obtained by the odor type compound oxidation of resting in peace containing Friedel-Crafts reaction and pyrroles, is reacted Substrate is limited to.β-carbonyl nitrile compounds prepare the pyroles chemical combination that 2 dicarbapentaborane replace with pyrroles by cascade reaction Thing has no report, and such compound has broad application prospects in terms of the multiformity synthesis of drug molecule.
Content of the invention
Present invention solves the technical problem that there is provided a kind of 2 dicarbapentaborane substituted azole class compounds and its preparation side Method, the method are that 2,6,6- tetramethyl piperidines are aoxidized in 4- oxygen -2 by substituent indole compound with β-carbonyl nitrile compounds Thing(4-oxo-TEMPO)In the presence of by cascade reaction synthesize 2 dicarbapentaborane substituted azole class compounds.
The present invention is adopted the following technical scheme that for solving above-mentioned technical problem:A kind of 2 dicarbapentaborane substituted azole class chemical combination Thing, it is characterised in that with following general structure:
Wherein R1For hydrogen, alkyl or benzyl, R2For phenyl, substituted-phenyl, furyl or thienyl, taking on substituted-phenyl phenyl ring Dai Jiwei fluorine, chlorine, bromine, methyl or methoxy.
Further preferably, 2 described dicarbapentaborane substituted azole class compounds are one of following compounds:
.
The preparation method of 2 dicarbapentaborane substituted azole class compound of the present invention, it is characterised in that concretely comprise the following steps: By substituted azole class compound 1, β-carbonyl nitrile compounds 2 and 4- oxo -2,2,6,6- tetramethyl piperidine oxides(4-oxo- TEMPO)In the presence of copper salt, 2 dicarbapentaborane are obtained by one kettle way multicomponent cascade reaction in acid flux material and are taken For azoles 3, the reaction equation of preparation process is:
.
Further preferably, described substituted azole class compound, β-carbonyl nitrile compounds, 4- oxygen -2,2,6,6- tetramethyls The mol ratio of phenylpiperidines oxide and copper salt is 1:1-1.5:2-3:0.05-0.2.
Further preferably, described copper salt is CuCl, CuCl2、CuBr、CuBr2Or Cu (OTf)2.
Further preferably, described acid flux material is acetic acid, propanoic acid or butanoic acid.
Further preferably, the reaction temperature in course of reaction is 25-120 DEG C.
The present invention has synthesized 2 two carbonyls by substituted azole class compound and β-carbonyl nitrile compounds by cascade reaction Base substituted azole class compound, is its further derivatization research, synthesizes the drug molecule containing pyrrole structure and lay a good foundation.
Specific embodiment
By the following examples the above of the present invention is described in further details, but this should not be interpreted as this The scope for inventing above-mentioned theme is only limitted to below example, and all technology that is realized based on the above of the present invention belong to this Bright scope.
Analytical tool and reagent:Proton nmr spectra is recorded with 400 type nuclear magnetic resonance analyser of Bruker ASCEND, chemical potential The unit for moving d is ppm.All reaction dissolvents conventionally carry out purification.Column chromatography silica gel(200-300 mesh)For green grass or young crops Island marine chemical industry subsidiary factory produces.Thin layer chromatography, using the efficient plates of GF254, is Yantai chemical institute production.Preparative thin layer Analysis plate is prepared by oneself, and fixing phase adopts GF254(HG/T2354-92)Silica gel and sodium carboxymethyl cellulose(800-1200)System Standby, respectively Qingdao Marine Chemical Co., Ltd. and Chinese Medicine(Group)Solution on Chemical Reagents in Shanghai company produces.All solvents are equal For analytical reagent, agents useful for same is purchased from Chemical Reagent Co., Ltd., Sinopharm Group.Aobvious using methods such as iodine, Ultraluminescences Color.Removing organic solvent under reduced pressure is carried out in Rotary Evaporators.
Embodiment 1
3-1
By 35 μ L of starting compound pyrroles(0.5mmol), benzoyl acetonitrile 109mg(0.75mmol), 4- oxos -2,2,6,6- four Methyl piperidine oxide 255mg(1.5 mmol)And CuCl 5mg(0.05mmol)3mL glacial acetic acid is dissolved in, reaction system is open React 5 hours in 80 DEG C, boil off acetic acid 50mL, plus ethyl acetate dissolving residue, washed twice with saturated sodium bicarbonate solution (10mL×2), organic layer is separated, anhydrous sodium sulfate drying is filtered, and revolving removes solvent, and pillar layer separation obtains compound 3-1 Sterling 88mg(Yield 93%).
1H NMR (400 MHz, DMSO-D6) δ 12.51 (brs, 1H), 7.92 (d,J= 7.1 Hz, 2H), 7.76 (t,J= 7.4 Hz, 1H), 7.61 (t,J= 7.7 Hz, 2H), 7.43-7.38 (m, 1H), 6.91- 6.80 (m, 1H), 6.33-6.29 (m, 1H).
Embodiment 2
3-2
In addition to replacing benzoyl acetonitrile using 4- chlorobenzoylacetonitriles, to prepare with prepare compound 3-1 identical method Compound 3-2.
1H NMR (400 MHz, CDCl3) δ 9.99 (brs, 1H), 8.03 (d,J= 8.6 Hz, 2H), 7.50 (d,J= 8.6 Hz, 2H), 7.28-7.24 (m, 1H), 7.13-7.02 (m, 1H), 6.42-6.36 (m, 1H).
Embodiment 3
3-3
Except using 4- toluyls acetonitrile replace benzoyl acetonitrile in addition to, with prepare compound 3-1 identical method system Standby compound 3-3.
1H NMR (400 MHz, CDCl3) δ 9.88 (brs, 1H), 7.94 (d,J= 8.2 Hz, 2H), 7.30 (d,J= 8.1 Hz, 2H), 7.23-7.19 (m, 1H), 7.05-6.96 (m, 1H), 6.38-6.32 (m, 1H), 2.43 (s, 3H).
Embodiment 4
3-4
Except using 4- methoxybenzoyl acetonitriles replace benzoyl acetonitrile in addition to, with prepare compound 3-1 identical method Prepare compound 3-4.
1H NMR (400 MHz, CDCl3) δ 9.71 (brs, 1H), 8.04 (d,J= 8.8 Hz, 2H), 7.23-7.17 (s, 1H), 7.07-7.01 (m, 1H), 6.98 (t,J= 8.9 Hz, 2H), 6.37 (dd,J= 3.7, 2.3 Hz, 1H), 3.90 (s, 3H).
Embodiment 5
3-5
Except using 4- Fluorobenzoyls acetonitrile replace benzoyl acetonitrile in addition to, with prepare compound 3-1 identical method system Standby compound 3-5.
1H NMR (400 MHz, CDCl3) δ 10.32 (brs, 1H), 8.11 (dd,J= 8.7, 5.4 Hz, 2H), 7.25-7.22 (m, 1H), 7.18 (t,J= 8.6 Hz, 2H), 7.09-7.02 (m, 1H), 6.38 (dd,J= 3.6, 2.3 Hz, 1H).
Embodiment 6
3-6
In addition to replacing benzoyl acetonitrile using thiophene -2- formyls acetonitrile, to prepare with prepare compound 3-1 identical method Compound 3-6.
1H NMR (400 MHz, CDCl3) δ 10.09 (brs, 1H), 8.09 (s, 1H), 7.82 (dd,J= 4.9, 1.0 Hz, 1H), 7.35-7.28 (m, 1H), 7.25-7.21 (m, 1H), 7.19 (dd,J= 4.9, 3.9 Hz, 1H), 6.41-6.35 (m, 1H).
Embodiment 7
3-7
In addition to replacing benzoyl acetonitrile using furan -2- formyls acetonitrile, to prepare with prepare compound 3-1 identical method Compound 3-7.
1H NMR (400 MHz, CDCl3) δ 10.32 (brs, 1H), 7.85-7.77 (m, 1H), 7.76- 7.58 (m, 1H), 7.38 (d,J= 3.4 Hz, 1H), 7.29 (d,J= 3.2 Hz, 1H), 6.68 (d,J = 2.5 Hz, 1H), 6.45 (d,J= 2.9 Hz, 1H).
Embodiment 8
3-8
Except using 2- chlorobenzoyls acetonitrile replace benzoyl acetonitrile in addition to, with prepare compound 3-1 identical method system Standby compound 3-8.
1H NMR (400 MHz, CDCl3) δ 9.96 (brs, 1H), 7.76 (dd,J= 7.6, 1.6 Hz, 1H), 7.50 (ddd,J= 8.1, 7.3, 1.7 Hz, 1H), 7.47-7.37 (m, 2H), 7.23-7.15 (m, 2H), 6.44-6.36 (m, 1H).
Embodiment 9
3-9
Except using 3- chlorobenzoyls acetonitrile replace benzoyl acetonitrile in addition to, with prepare compound 3-1 identical method system Standby compound 3-9.
1H NMR (400 MHz, CDCl3) δ 10.15 (brs, 1H), 8.07 (t,J= 1.8 Hz, 1H), 8.02-7.92 (m, 1H), 7.63 (ddd,J= 8.0, 2.1, 1.0 Hz, 1H), 7.47 (t,J= 7.9 Hz, 1H), 7.31-7.25 (m, 1H), 7.13-7.04 (m, 1H), 6.42 – 6.38 (m, 1H);13C NMR (101 MHz, CDCl3) δ 191.2, 135.2, 134.9, 134.6, 130.3, 130.1, 129.1, 128.5, 122.4, 112.6.
Embodiment 10
3-10
Except using 3- bromobenzoyls acetonitrile replace benzoyl acetonitrile in addition to, with prepare compound 3-1 identical method system Standby compound 3-10.
1H NMR (400 MHz, CDCl3) δ 10.06 (brs, 1H), 8.20 (t,J= 1.7 Hz, 1H), 7.99 (d,J= 7.8 Hz, 1H), 7.77 (ddd,J= 8.0, 1.9, 1.0 Hz, 1H), 7.39 (t,J= 7.9 Hz, 1H), 7.29-7.23 (m, 1H), 7.09-7.02 (m, 1H), 6.42-6.35 (m, 1H).
Embodiment 11
3-11
Except using 3- methoxybenzoyl acetonitriles replace benzoyl acetonitrile in addition to, with prepare compound 3-1 identical method Prepare compound 3-11.
1H NMR (400 MHz, CDCl3) δ 10.02 (brs, 1H), 7.64 – 7.53 (m, 2H), 7.40 (t,J= 7.9 Hz, 1H), 7.27-7.15 (m, 2H), 7.03 (d,J= 2.7 Hz, 1H), 6.36 (d,J = 2.1 Hz, 1H), 3.87 (s, 3H).
Embodiment 12
3-12
Except using 2- methoxybenzoyl acetonitriles replace benzoyl acetonitrile in addition to, with prepare compound 3-1 identical method Prepare compound 3-12.
1H NMR (400 MHz, CDCl3) δ 10.07 (br s, 1H), 7.91 (dd,J= 7.7, 1.7 Hz, 1H), 7.62-7.51 (m, 1H), 7.18-7.03 (m, 1H), 7.13-7.06 (m, 1H), 6.95 (d,J= 8.4 Hz, 1H), 6.90 (d,J= 3.5 Hz, 1H), 6.35 – 6.29(m, 1H), 3.65 (s, 3H).
Embodiment 13
3-13
Except using N- methylpyrroles replace pyrroles in addition to, with prepare compound 3-1 identical method prepare compound 3-13.
1H NMR (400 MHz, CDCl3) δ 8.04-7.94 (m, 2H), 7.61 (t,J= 7.4 Hz, 1H), 7.48 (t,J= 7.7 Hz, 2H), 6.99 (s, 1H), 6.86 (dd,J= 4.2, 1.5 Hz, 1H), 6.17 (dd,J= 4.2, 2.4 Hz, 1H), 4.08 (s, 3H).
Embodiment 14
3-14
Except using N- N-ethyl pyrrole N -s replace pyrroles in addition to, with prepare compound 3-1 identical method prepare compound 3-14.
1H NMR (400 MHz, CDCl3) δ 7.99 (d,J= 7.5 Hz, 2H), 7.61 (t,J= 7.4 Hz, 1H), 7.48 (t,J= 7.7 Hz, 2H), 7.09-7.06 (m, 1H), 6.87 (d,J= 3.8 Hz, 1H), 6.18 (dd,J= 3.9, 2.5 Hz, 1H), 4.48 (q,J= 7.1 Hz, 2H), 1.48 (t,J= 7.2 Hz, 3H).
Embodiment 15
3-15
Except using N- benzyl-pyrroles replace pyrroles in addition to, with prepare compound 3-1 identical method prepare compound 3-15.
1H NMR (400 MHz, CDCl3) δ 7.82-7.77 (m, 2H), 7.61-7.54 (m, 1H), 7.41 (t, J = 7.8 Hz, 2H), 7.38-7.28 (m, 3H), 7.22-7.16 (m, 2H), 7.14-7.10 (m, 1H), 6.96 (dd, J = 4.2, 1.6 Hz, 1H), 6.25 (dd, J = 4.2, 2.5 Hz, 1H), 5.69 (s, 2H).
Ultimate principle, principal character and the advantage of the present invention is embodiment above describes, the technical staff of the industry should Understand, the present invention is not restricted to the described embodiments, the original that the present invention is simply described described in above-described embodiment and description Reason, under the scope without departing from the principle of the invention, the present invention also has various changes and modifications, and these changes and improvements each fall within In the scope of protection of the invention.

Claims (7)

1. a kind of 2 dicarbapentaborane substituted azole class compounds, it is characterised in that with following general structure:
Wherein R1For hydrogen, alkyl or benzyl, R2For phenyl, substituted-phenyl, furyl or thienyl, taking on substituted-phenyl phenyl ring Dai Jiwei fluorine, chlorine, bromine, methyl or methoxy.
2. 2 dicarbapentaborane substituted azole class compound according to claim 1, it is characterised in that 2 described dicarbapentaborane Substituted azole class compound is one of following compounds:
.
3. the preparation method of 2 dicarbapentaborane substituted azole class compounds described in a kind of claim 1, it is characterised in that concrete walk Suddenly it is:By substituted azole class compound 1, β-carbonyl nitrile compounds 2 and 4- oxo -2,2,6,6- tetramethyl piperidine oxides 4- Oxo-TEMPO is obtained 2 dicarbapentaborane by one kettle way multicomponent cascade reaction in the presence of copper salt in acid flux material Substituted azole class compound 3, the reaction equation of preparation process is:
.
4. the preparation method of 2 dicarbapentaborane substituted azole class compound according to claim 3, it is characterised in that:Described Substituted azole class compound, β-carbonyl nitrile compounds, 4- oxygen -2,2,6,6- tetramethyl piperidine oxides and copper salt Mol ratio is 1:1-1.5:2-3:0.05-0.2.
5. the preparation method of 2 dicarbapentaborane substituted azole class compound according to claim 3, it is characterised in that:Described Copper salt be CuCl, CuCl2、CuBr、CuBr2Or Cu (OTf)2.
6. the preparation method of 2 dicarbapentaborane substituted azole class compound according to claim 3, it is characterised in that:Described Acid flux material be acetic acid, propanoic acid or butanoic acid.
7. the preparation method of 2 dicarbapentaborane substituted azole class compound according to claim 3, it is characterised in that:Reaction During reaction temperature be 25-120 DEG C.
CN201610876090.XA 2016-10-08 2016-10-08 A kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof Active CN106496091B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610876090.XA CN106496091B (en) 2016-10-08 2016-10-08 A kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610876090.XA CN106496091B (en) 2016-10-08 2016-10-08 A kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof

Publications (2)

Publication Number Publication Date
CN106496091A true CN106496091A (en) 2017-03-15
CN106496091B CN106496091B (en) 2018-05-22

Family

ID=58294408

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610876090.XA Active CN106496091B (en) 2016-10-08 2016-10-08 A kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106496091B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106966949A (en) * 2017-05-31 2017-07-21 南京佰泰克生物技术有限公司 Compound and its preparation of a kind of raising NK cells to stomach cancer lethality
CN107011236A (en) * 2017-05-31 2017-08-04 南京佰泰克生物技术有限公司 A kind of compound and its preparation for improving CIK cell to stomach cancer lethality

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102249879A (en) * 2011-05-18 2011-11-23 浙江大学 1,2-diketone derivant and preparation method thereof
CN105348060A (en) * 2015-12-14 2016-02-24 江苏强盛功能化学股份有限公司 Preparation method of 1,2-diketone derivative
CN105566198A (en) * 2016-02-22 2016-05-11 新乡医学院 3-dicarbonyl substitution indole compound and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102249879A (en) * 2011-05-18 2011-11-23 浙江大学 1,2-diketone derivant and preparation method thereof
CN105348060A (en) * 2015-12-14 2016-02-24 江苏强盛功能化学股份有限公司 Preparation method of 1,2-diketone derivative
CN105566198A (en) * 2016-02-22 2016-05-11 新乡医学院 3-dicarbonyl substitution indole compound and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHIEN-TIEN CHEN等: "Enantioselective Aerobic Oxidation of α-Hydroxy-Ketones Catalyzed by Oxidovanadium(V) Methoxides Bearing Chiral, N-Salicylidene-tert-butylglycinates", 《ORGANIC LETTERS》 *
JIANWEI YAN等: "The dicarbonylation of indoles via Friedel–Crafts reaction with dicarbonyl nitrile generated in situ and retro-cyanohydrination", 《RSC ADVANCES》 *
ROBERT J. JONES等: "Photocyclisation Strategy for the Synthesis of Antiturnour Agent CC-1065: Synthesis of Thiophene Analogues of PDE-l and PDE-II", 《JOURNAL OF THE CHEMICAL SOCIETY》 *
SILVIO MASSA等: "Pyrrylphenylethanones Related to Cathinone and Lefetamine Synthesis and Pharmacological Activities", 《ARCHIV DER PHARMAZIE (WEINHEIM, GERMANY)》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106966949A (en) * 2017-05-31 2017-07-21 南京佰泰克生物技术有限公司 Compound and its preparation of a kind of raising NK cells to stomach cancer lethality
CN107011236A (en) * 2017-05-31 2017-08-04 南京佰泰克生物技术有限公司 A kind of compound and its preparation for improving CIK cell to stomach cancer lethality

Also Published As

Publication number Publication date
CN106496091B (en) 2018-05-22

Similar Documents

Publication Publication Date Title
CN103524440B (en) The preparation method of gout therapertics Lesinurad and Lesinurad intermediate
US9150538B2 (en) Method for producing 4, 4-difluoro-3,4-dihydroisoquinoline derivatives
TWI722979B (en) 5-fluoro-4-imino-3-(alkyl/substituted alkyl)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one and processes for their preparation
CN106496091B (en) A kind of 2 dicarbapentaborane substituted azole class compounds and preparation method thereof
CN108640917A (en) A kind of synthetic method of indoles simultaneously [2,1-a] isoquinoline compound
CN107602452B (en) Synthetic method of 3-acyl pyridine compound
CN106046002B (en) A kind of synthetic method of pyridine-imidazole simultaneously [1,2,3] triazoloquinoline class compound
CN105985280A (en) Difluoromethylthiolation reagent, and preparation method and application thereof
CN105566198B (en) A kind of 3 dicarbapentaborane substituent indole compounds and preparation method thereof
CN112154140A (en) Compound and application thereof in synthesizing bulk drug of Brivaracetam (Brivaracetam)
CN110483387A (en) A kind of method of one pot process nicotimine amide derivatives
CN105820174A (en) Polysubstituted thienoindole derivative and preparation method thereof
JP2016198736A (en) Catalyst having amino-salicylaldimine ligand coordinated to metal and method for producing iodine cyclized product using the same
CN107722007B (en) Preparation method of apixaban impurity
CN106083810A (en) A kind of preparation method of polysubstituted thiochromanone derivant
CN110483391A (en) A kind of five component synthetic methods of nicotimine amide derivatives
CN110357790A (en) Compound and its purposes in synthesis Bu Waxitan bulk pharmaceutical chemicals
CN101410386B (en) 2-alkenyl-3-aminothiophene derivative and process for producing thereof
CN104136422A (en) Compound, method for producing compound, and method for purifying compound
CN103864691A (en) Method for preparing compound ABT-869
CN107089950B (en) Method for synthesizing 4-acylpyrazole compound from non-cyclic ketohydrazone
CN115974879B (en) Preparation method of polysubstituted imidazo heterocyclic compound
RU2626957C2 (en) 2,6-dihalo-5-alkoxy-4-substituted-pirimidines, pirimidine-carbaldehides and methods of formation and use
JPWO2013027835A1 (en) Process for producing optically active naphthalene compounds
CN105037238B (en) A kind of 3 3-position substituted indole three-level alcohol compounds and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant